Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00233909
Status:
COMPLETED
Last Update Posted:
2008-04-01
First Post:
2005-10-04
Brief Title:
A Trial of Gemtuzumab Ozogamicin GO in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia
Sponsor:
Kanisa Pharmaceuticals
Organization:
Kanisa Pharmaceuticals